Milestone Pharmaceuticals
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $108 | $0 |
Gross Profit | -28 | -27 | 54 | -25 |
EBITDA | -11,987 | -19,892 | -12,322 | -8,572 |
EBIT | -12,015 | -19,919 | -12,348 | -8,597 |
Net Income | -12,966 | -20,761 | -12,363 | -9,439 |
Net Change In Cash | 0 | 0 | 108 | 0 |
Free Cash Flow | -12,577 | -13,952 | -6,865 | -7,022 |
Cash | 42,499 | 45,085 | 25,314 | 12,799 |
Basic Shares | 66,380 | 66,285 | 62,210 | 66,190 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $1,000 | $5,000 | $15,000 |
Gross Profit | -646 | 1,000 | 5,000 | 15,000 |
EBITDA | -42,102 | -56,845 | -59,553 | -42,980 |
EBIT | -38,197 | -56,937 | -59,642 | -43,342 |
Net Income | -41,519 | -59,685 | -57,134 | -42,633 |
Net Change In Cash | 0 | 1,000 | 5,000 | 15,000 |
Cost of Revenue | 41,831 | |||
Free Cash Flow | -28,881 | -46,536 | -52,741 | -33,224 |
Cash | 25,314 | 13,760 | 7,636 | 114,141 |
Basic Shares | 62,210 | 42,955 | 42,450 | 41,833 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | $0 |
2025-06-30 | -$0.20 |
2025-03-31 | -$0.31 |
2024-12-31 | -$0.19 |
